Abiopharma

🔍 O'Hara John Charles (Executive)

Company: SEALSQ Corp (LAES)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Sold 10,000 shares of Ordinary Shares at $2.4532 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 255,595.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 10,000 shares of Ordinary Shares at $2.4173 per share (Direct)
  Date: 2026-04-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 245,595.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.51, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.3625 to $2.52, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.